IRLAB Therapeutics AB (publ) Cash Flow-to-Debt Ratio
IRLAB Therapeutics AB (publ) cash flow-to-debt ratio. IRLAB Therapeutics AB (publ) (IRLAB-A) has a Cash Flow-to-Debt Ratio of -0.22x as of December 2025, meaning its operating cash flow of Skr-24.18 Million could theoretically repay 0% of its total liabilities (Skr107.49 Million) in one year. Check IRLAB-A cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of IRLAB Therapeutics AB (publ) (2014–2025)
Cash flow-to-debt ratio of IRLAB Therapeutics AB (publ) from 2014 to 2025. Historical debt coverage capacity for IRLAB Therapeutics AB (publ) across 12 annual periods. Check IRLAB Therapeutics AB (publ) investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
IRLAB Therapeutics AB (publ) Cash Flow-to-Debt Ratio by Year (2014–2025)
IRLAB Therapeutics AB (publ) cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for IRLAB Therapeutics AB (publ). For the full cash flow conversion analysis, see IRLAB Therapeutics AB (publ) (IRLAB-A) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.51x | Skr-55.22 Million | Skr107.49 Million | ▲ +18.9% |
| 2024 | -0.63x | Skr-65.59 Million | Skr103.58 Million | ▲ +76.4% |
| 2023 | -2.69x | Skr-164.85 Million | Skr61.36 Million | ▲ +38.3% |
| 2022 | -4.36x | Skr-142.61 Million | Skr32.72 Million | ▼ -347.2% |
| 2021 | 1.76x | Skr128.64 Million | Skr72.97 Million | ▲ +143.8% |
| 2020 | -4.02x | Skr-89.21 Million | Skr22.19 Million | ▼ -15.7% |
| 2019 | -3.48x | Skr-91.20 Million | Skr26.24 Million | ▲ +38.8% |
| 2018 | -5.68x | Skr-70.79 Million | Skr12.46 Million | ▲ +21.6% |
| 2017 | -7.24x | Skr-57.74 Million | Skr7.97 Million | ▼ -63.7% |
| 2016 | -4.43x | Skr-40.82 Million | Skr9.22 Million | ▼ -45.1% |
| 2015 | -3.05x | Skr-27.66 Million | Skr9.06 Million | ▼ -394.1% |
| 2014 | -0.62x | Skr-11.02 Million | Skr17.86 Million | — |